Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00030069 · ClinicalTrials.gov registry record · Phase 2
Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
A Phase 2 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT00030069 is a Phase 2 study that has completed, run by University of Pittsburgh. The registered enrollment target is 32 participants.
The verdict
NCT00030069, a Phase 2 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a study to determine the response rate in patients with myelodysplastic syndromes treated with calcitriol and dexamethasone.
Interventions
- DRUG Dexamethasone
- DRUG Calcitriol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2001-09 |
| Est. Completion | 2009-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00030069
The ClinicalTrials.gov registry entry for NCT00030069 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone is the first listed.
NCT00030069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00030069 about?
NCT00030069 is a clinical study titled "Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes". This is a study to determine the response rate in patients with myelodysplastic syndromes treated with calcitriol and dexamethasone.
What is the current status of trial NCT00030069?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2001-09. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00030069?
The interventions under investigation include: Dexamethasone (DRUG), Calcitriol (DRUG).
Who is sponsoring clinical trial NCT00030069?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.